A remarkable excess mortality has coincided with the COVID-19 pandemic in Europe. We
present preliminary pooled estimates of all-cause mortality for 24 European countries/federal …

Importance In low-income countries, live measles vaccine reduces mortality from causes
other than measles infection. Such nonspecific effects of vaccines might also be important for …

Since December 2016, excess all-cause mortality was observed in many European
countries, especially among people aged ≥ 65 years. We estimated all-cause and influenza-…

Objectives Weekly monitoring of European all-cause excess mortality, the EuroMOMO
network, observed high excess mortality during the influenza B/Yamagata dominated 2017/18 …

Context Assessment of the fetal safety of vaccination against influenza A(H1N1)pdm09 in
pregnancy has been limited. Objective To investigate whether exposure to an adjuvanted …

The European monitoring of excess mortality for public health action (EuroMOMO) network
monitors weekly excess all-cause mortality in 27 European countries or subnational areas. …

Objective To investigate whether an adjuvanted pandemic A/H1N1 2009 influenza vaccine
in pregnancy was associated with an increased risk of fetal death. Design Nationwide …

We estimated interim influenza A vaccine effectiveness (VE) following a late sharp rise in
cases during an influenza A(H3N2)-dominated 2021/22 season, after lifting COVID-19 …

Both the USA and Europe experienced substantial excess mortality in 2020 and 2021
related to the COVID-19 pandemic. Methods used to estimate excess mortality vary, making …

Objective: To determine the risk of adverse pregnancy outcome by maternal serum alpha-fetoprotein
(MSAFP) level. Methods: We followed 77,149 pregnant women and their infants …